Download PDF
Thromb Haemost 1977; 38(04): 0955-0962
DOI: 10.1055/s-0038-1651913
Original Article
Schattauer GmbH

Platelets and Fibrinolysis

J. Heinrich Joist
1   Departments of Medicine and Pathology, Washington University School of Medicine, St. Louis, Missouri, U.S.A.
› Author AffiliationsSupported in part by grant HL 14147-06 (Specialized Center for Research in Thrombosis)
Further Information

Publication History

Publication Date:
04 July 2018 (online)

    Permissions and Reprints

Summary

Blood platelets play a crucial role in the response of blood to vascular injury through adherence to exposed subendothelial vessel wall structures, the subsequent release of substances which trigger platelet aggregation, and release-associated changes in platelet surface properties which facilitate the interaction of coagulation factors, leading to the formation of fibrin necessary for stabilization of the initial hemostatic plug. There is substantial evidence from in vitro studies to suggest that platelets may also affect the fibrinolytic plasminogen-plasmin system thought to be one of the important hemostatic regulatory mechanisms preventing inappropriate extension of the hemostatic plug which may lead to thrombotic vessel occlusion. In this paper, the published experimental evidence concerning the effects of platelets and platelet-associated factors on the activation and function of the plasminogen-plasmin system is reviewed. The experimental findings indicate that platelets may contribute to fibrin clot stabilization through the release of substances from their storage organelles which inhibit both plasminogen activation and the action of plasmin. The physiologic and pathophysiologic significance of platelet-mediated inhibition of fibrinolysis by plasmin, as well as other potentially important plasma and cellular fibrinolytic enzymes, is still largely subject to speculation and appears to be an important area for future investigation.

 

  • References

  • 1 Alkjaersig N. 1961. The antifibrinolytic activity of platelets. Blood Platelets, Henry Ford Hospital International Symposium. Little, Brown and Company; Boston: 329.
    Google Scholar
  • 2 Bennett N. B. 1970; Further studies of an inhibitor of plasminogen activation in human serum. Release of the inhibitor during coagulation and thrombus formation. Thrombosis et Diathesis Haemorrhagia 23: 553.
    PubMedGoogle Scholar
  • 3 Bergstein J. M. 1977; Platelet inhibition of renal cortical fibrinolytic activity in the rabbit. Laboratory Investigation 35: 171.
    PubMedGoogle Scholar
  • 4 Broekman M. L, Handin R. I, Derksen A, Cohen P. 1976; Distribution of phospholipids, fatty acids and platelet factor 3-activity among subcellular fractions of human platelets. Blood 47: 963.
    PubMedGoogle Scholar
  • 5 Caen J. 1961; Plaquettes sanguines et fibrinolyse. Pathologie et Biologie 9: 1501.
    PubMedGoogle Scholar
  • 6 Davie E. W, Fujikawa K, Legaz M. E, Kato H. 1975. Proteases and Biological Control. Cold Spring Harbor Laboratory; New York: 65.
    Google Scholar
  • 7 Den Ottolander G. J. H, Leijnse B, Cremer-Elfrink H. M. J. 1967; Plasmatic and platelet anti-plasmins and anti-activa tors. Thrombosis et Diathesis Haemorrhagia 18: 404.
    PubMedGoogle Scholar
  • 8 Ekert H, Friedlander I, Hardisty R. M. 1970; The role of platelets in fibrinolysis. Studies on the plasminogen activator and antiplasmin activity of platelets. British Journal of Haematology 18: 575.
    CrossrefPubMedGoogle Scholar
  • 9 Ganguly P, Moore R. 1967; Studies on human platelet proteins. Clinica Chimica Acta 17: 153.
    CrossrefPubMedGoogle Scholar
  • 10 Greig H. B. W, Cornelius E. M. 1961; The proactivator activity of platelets. South African Journal of Medical Sciences 26: 101.
    PubMedGoogle Scholar
  • 11 Holemans R, Gross R. 1961; a Influence of blood platelets on fibrinolysis. Thrombosis et Diathesis Haemorrhagica 6: 196.
    PubMedGoogle Scholar
  • 12 Holemans R, Gross R. 1961; b Fibrinolytic activities present in human blood platelets. Thrombosis et Diathesis Haemorrhagica 189: 238.
    PubMedGoogle Scholar
  • 13 Hougie C, Ayers F. 1960; Lipaemia and fibrinolytic potentiality. Lancet II: 196.
    PubMedGoogle Scholar
  • 14 Hume R. 1958; An inhibitory effect of platelets on fibrinolysis. Scottish Medical Journal 3: 479.
    CrossrefPubMedGoogle Scholar
  • 15 Johnson S. A, Schneider C. L. 1953; The existence of antifibrinolytic activity in platelets. Science 117: 229.
    CrossrefPubMedGoogle Scholar
  • 16 Joist J. H, Dolezel G, Lloyd J. V, Kinlough-Rathbone R. L, Mustard J. F. 1974; Platelet factor 3-availability and the platelet release reaction. Journal of Laboratory and Clinical Medicine 84: 474.
    PubMedGoogle Scholar
  • 17 Joist J. H, Niewiarowski S, Mustard J. F. 1971; Release of antiplasma during thrombin or collagen induced platelet aggregation. Thrombosis Diathesis Haemorrhagica Suppl. 47: 113.
    PubMedGoogle Scholar
  • 18 Joist J. H, Niewiarowski S. 1973; Retention of fibrin stabilizing factor during the platelet release reaction. Thrombosis et Diathesis Haemorrhagica 29: 679.
    PubMedGoogle Scholar
  • 19 Joist J. H, Niewiarowski S, Nath N, Mustard J. F. 1976; Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterisation, and relationship to antiheparin in pig platelets. Journal of Laboratory and Clinical Medicine 87: 659.
    PubMedGoogle Scholar
  • 20 Jürgens J, Pryzbilski R. 1968; Antifibrinolytic activity of platelets. Experimental Biology and Medicine 3: 181.
    PubMedGoogle Scholar
  • 21 Kinlough-Rathbone R. L, Reimers H. J, Mustard J. F, Packham M. A. 1976; Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science 192: 1011.
    CrossrefPubMedGoogle Scholar
  • 22 Kwaan H. C, Suwanwela N. 1971; Inhibitors of fibrinolysis in platelets in polycythemia and thrombocytosis. British Journal of Haematology 21: 313.
    CrossrefPubMedGoogle Scholar
  • 23 McDonagh J, Kiesselbach T. H, Wagner R. H. 1969; Factor XIII and antiplasmin activity in human platelets. American Journal of Physiology 216: 508.
    PubMedGoogle Scholar
  • 24 Moroz L. A, Gilmore N. J. 1976; Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system. Blood 48: 531.
    PubMedGoogle Scholar
  • 25 Moroz L. A. 1977; Increased blood fibrinolytic activity after aspirin ingestion. New England Journal of Medicine 296: 525.
    CrossrefPubMedGoogle Scholar
  • 26 Murray J, Crawford G. P. M, Ogston D, Douglas A. S. 1974; Studies on an inhibitor of plasminogen activators in human platelets. British Journal of Haematology 26: 661.
    CrossrefPubMedGoogle Scholar
  • 27 Mustard J. F, Kinlough-Rathbone R. L, Packham M. A. 1974. Recent status of research in the pathogenesis of thrombosis. In: Thrombosis: pathogenesis and clinical trials. F. K. Schattauer Verlag; Stuttgart: 157.
    Google Scholar
  • 28 Nachman R. L. 1965; Immunologic studies of platelet proteins. Blood 25: 703.
    PubMedGoogle Scholar
  • 29 Nachman R. L, Harper P. C. 1976; Platelet α2-macroglobulin and α1-antitrypsin. Journal of Biological Chemistry 251: 4514.
    PubMedGoogle Scholar
  • 30 Nalli G, Cattaneo G, Malemani G. D, Majolino I, Fornasari P. M, Almasio P, Piovella F, Ascari E. 1977; Immunofluorescent detection of α1-antitrypsin in platelets and megakaryocytes. Thrombosis Research 10: 613.
    CrossrefPubMedGoogle Scholar
  • 31 Østerud B, Rapaport S. I, Lavine K. 1977; Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood 49: 819.
    PubMedGoogle Scholar
  • 32 Reid W. O, Silver M. J. 1964; Activation of the blood fibrinolytic enzyme system by platelets. American Journal of Physiology 206: 1255.
    PubMedGoogle Scholar
  • 33 Schick P. K, Kurica K. B, Chaco G. K. 1976; Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. Journal of Clinical Investigation 57: 1221.
    CrossrefPubMedGoogle Scholar
  • 34 Ulutin S. B, Aktuglu G. 1974; The release of platelet antiplasmins. New Istanbul Contribution to Clinical Science 11: 24.
    PubMedGoogle Scholar
  • 35 Wakabayashi K, Fujikawa K, Abe T. 1970; Some properties of an antiplasmin substance from rabbit platelets. Thrombosis et Diathesis Haemorrhagica 24: 76.
    PubMedGoogle Scholar
  • 36 Walsh P. N. 1972; a The role of platelets in the contact phase of blood coagulation. British Journal of Haematology 22: 237.
    CrossrefPubMedGoogle Scholar
  • 37 Walsh P. N. 1972; b The role of platelets in intrinsic factor Xa formation. British Journal of Haematology 22: 743.
    CrossrefPubMedGoogle Scholar
  • 38 Weiss H. J. 1975; Platelet physiology and abnormalities of platelet function. New England Journal of Medicine 293: 531.
    CrossrefPubMedGoogle Scholar